Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Clinuvel Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Growing Photomedicine Adoption Will Unlock Global Patient Markets
Key Takeaways Scaling a difficult-to-replicate infrastructure and direct distribution could accelerate revenue growth and sustain higher margins without the need for a traditional salesforce. Robust cash reserves and first-to-market, systemic therapies position Clinuvel for rapid regulatory and commercial gains in expanding underserved markets.
View narrative
AU$39.82
FV
69.2% undervalued
intrinsic discount
35.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Mahanagar Gas
AN
AnalystHighTarget
Consensus Narrative from 29 Analysts
Mumbai Urban Migration And Cleaner Fuels Will Spark Growth
Key Takeaways Consolidation, urban expansion, and regulatory delays in public transport electrification will drive outsized volume growth and margin improvements across core gas and CNG businesses. Diversification into green ventures and sustained low input costs will strengthen competitive positioning, supporting high-margin revenue streams and robust long-term earnings growth.
View narrative
₹1.95k
FV
31.4% undervalued
intrinsic discount
10.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Bravura Solutions
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
APAC Wealth Platforms Will Grow With Aging Demand And Risks
Key Takeaways Structural tailwinds from digital adoption and regulatory complexity support robust, recurring growth and improved operational leverage for Bravura in APAC and globally. Effective client acquisition, decentralized leadership incentives, and wealth sector trends position Bravura for long-term margin expansion and premium pricing power.
View narrative
AU$2.95
FV
25.8% undervalued
intrinsic discount
-3.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Tofas Türk Otomobil Fabrikasi Anonim Sirketi
AN
AnalystHighTarget
Consensus Narrative from 13 Analysts
Rising Turkish Markets And EV Trends Will Expand Auto Demand
Key Takeaways Strong growth in local and export sales, strategic market positioning, and effective new model launches are set to drive sustained revenue and margin expansion. Accelerated Stellantis integration, plant investments, and leading EV capabilities will deliver substantial margin improvement, recurring revenue streams, and outperform market expectations.
View narrative
₺516.69
FV
54.0% undervalued
intrinsic discount
38.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Domino's Pizza Group
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Digital And Robotic Advances Will Capture Underserved Opportunities
Key Takeaways Automation, new store expansion, and robotics are expected to drive significant efficiency gains and create opportunities for accelerated growth beyond current market expectations. Enhanced digital platforms and loyalty programs could structurally increase order frequency, average basket size, and solidify long-term market leadership against pressured competitors.
View narrative
UK£4.50
FV
55.8% undervalued
intrinsic discount
7.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Domain Holdings Australia
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Australia's Urbanisation And Digital Adoption Will Revitalize Property Markets
Key Takeaways Accelerated AI-driven audience growth, premium product adoption, and digital service expansion are set to significantly boost engagement, pricing power, and diversified revenue streams. Structural property demand and deeper agent integration position Domain for sustained volume-driven growth, stronger network effects, and increasingly predictable, high-quality earnings.
View narrative
AU$4.43
FV
0.2% undervalued
intrinsic discount
9.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Petroreconcavo
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Digital Automation And Energy Security Will Reshape Brazil's Onshore Industry
Key Takeaways Innovative drilling, advanced recovery, and digitalization could unlock significant reserve growth, industry-leading margins, and profitability beyond current market expectations. Strong policy tailwinds, vertical integration, and a consolidation strategy may secure market dominance, resilient revenue, and transformative long-term growth opportunities.
View narrative
R$22.00
FV
41.9% undervalued
intrinsic discount
4.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Sharda Cropchem
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Rising Global Food Demand Will Spur Sustainable Crop Protection
Key Takeaways Margin expansion and profitability are likely to exceed expectations due to high-margin regional growth and accelerated market expansion from pending registrations. Strong cash generation and an agile, asset-light model position Sharda to boost shareholder returns and capitalize rapidly on sustainability-driven market trends.
View narrative
₹1.26k
FV
24.1% undervalued
intrinsic discount
15.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Mega Lifesciences
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Aging Populations And Emerging Markets Will Drive Wellness Demand
Key Takeaways Accelerated manufacturing expansion, robust product pipeline, and localization strategies position Mega Lifesciences for outperformance in topline growth and margin resilience. Early focus on prevention-oriented brands and proactive market adaptation may lead to dominant status and sustained earnings growth amid evolving health trends.
View narrative
฿39.00
FV
24.4% undervalued
intrinsic discount
6.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies